Upperton will apply its expertise to enable the next generation of Adenovirus-vectored vaccines to be delivered without needles.
Discover more about our team. In this Spotlight, meet our Project Coordinator, Sophie Skinner, on her journey with Upperton.
We’re delighted to have been shortlisted in two major categories at the Pharma Industry Awards UK 2025, recognising our growth.
How the body absorbs, distributes, metabolizes, and excretes a drug – differs significantly between the two modalities.
Discover how CDMO services support Finished Dosage Form (FDF) development, from formulation to manufacturing and regulatory compliance.
We’re delighted to announce that we’ve won the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.
Discover the critical product decisions in sterile drug formulation development. Learn how planning with your CDMO can streamline your path.
Discover why project management is the critical success factor for CDMO collaborations. Explore Upperton’s approach.
Nikki Whitfield, CEO of Upperton, has received the ‘CEO Excellence in Pharmaceutical Manufacturing’ Award at the CEO Today Global Awards 2025
Explore the key differences between Finished Dosage Forms (FDFs) and APIs in drug development and manufacturing.
Speak with our team of experts and set up a discovery call to discuss your project in more detail.